Results for peror translation from Latvian to English

peror li
oral use

peror ls š dums
oral solution

uzs cas aptuveni 60% peror l s devas.
approximately 60% of an oral dose is absorbed.

to var lietot kombin cij ar noteiktiem peror liem pretdiab ta l dzek iem.
it may be used in combination with certain oral antidiabetic drugs.

vien 2. tipa diab ta p t jum pacienti sa ma ar peror los pretdiab ta l dzek us.
in one study, patients with type 2 diabetes also received anti-diabetes medicines by mouth.

lietojot kombin cij ar peror liem pretdiab ta l dzek iem, novomix 30 deva ir j piel go.
when novomix 30 is used in combination with oral antidiabetic drugs the dosage should be adjusted.

absol t peror l biolo isk pieejam ba, sal dzinot ar intravenozu lietošanu, nav noteikta.
absolute oral bioavailability relative to intravenous administration has not been determined

vieglu hipoglik miju var rst t, peror li lietojot glikozi vai produktus, kuru sast v ir cukurs.
mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products.

p c peror las lietošanas veseliem cilv kiem vid jais beigu elimin cijas pusperiods bija atkar gs no vecuma un dzimuma.
after oral administration, the mean terminal elimination half-life of olanzapine in healthy subjects varied on the basis of age and gender.

atg stot sama u, pacientam ieteicams peror li lietot og hidr tus, lai izvair tos no atk rtotas hipoglik mijas.
upon regaining consciousness administration of oral carbohydrate is recommended for the patient in order to prevent relapse.

Š ietamais termin lais t1/ 2 p c 100 mg peror las sitaglipt na devas lietošanas bija aptuveni 12, 4 stundas.
the apparent terminal t1/ 2 following a 100-mg oral dose of sitagliptin was approximately 12.4 hours.

9 rezult ti, ko sniedz raloksif na vienreiz jas peror las devas p rbaudes, ir t di paši k vair kk rt ju devu farmakokin tikai.
results from single oral doses of raloxifene predict multiple dose pharmacokinetics.

vienlaikus aktiv t s ogles lietošana mazina olanzap na biolo isko pieejam bu p c peror las lietošanas par 50 – 60%.
the concomitant administration of activated charcoal was shown to reduce the oral bioavailability of olanzapine by 50 to 60%.

peror las oksibutin na ievad šanas rezult t var att st ties sekojoši trauc jumi, ta u š s par d bas netika nov rotas kl niskajos p t jumos ar kentera:
oral administration of oxybutynin may warrant the following cautionary statements, but these events were not observed during clinical trials with kentera:

rē nepieciešam bu p c insul na var palielin t š das vielas: peror lie pretapaug ošan s l dzek i, tiaz di, glikokortiko di, vairogdziedzera hormoni un beta
beta-blocking agents may mask the symptoms of hypoglycaemia and delay recovery from

novomix 30 var lietot gados vec ki pacienti, lai gan pieredze par novomix 30 lietošanu kombin cij ar peror liem pretdiab ta l dzek iem pacientiem, kuri vec ki par 75 gadiem, ir ierobežota.
novomix 30 can be used in elderly patients; however there is limited experience with the use of novomix 30 in combination with oads in patients older than 75 years.

tom r hipoglik mijai var b t vair kas pak pes: • vieglu hipoglik miju var rst t, peror li lietojot glikozi vai produktus, kuru sast v ir cukurs.
however, hypoglycaemia may develop over sequential stages: • mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products.

nepieciešam bu p c insul na var palielin t š das vielas: peror lie pretapaug ošan s l dzek i, tiaz di, glikokortiko di, vairogdziedzera hormoni, simpatomim tiskie l dzek i un danazols.
oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics and danazol.

nepieciešam bu p c insul na var palielin t š das vielas: peror lie pretapaug ošan s l dzek i, tiaz di, glikokortiko di, vairogdziedzera hormoni un beta simpatomim tiskie l dzek i, augšanas hormons un danazols.
oral contraceptives, thiazides, glucocorticoids, thyroid hormones and beta-sympathomimetics, growth hormone and danazol.

83 inhibitorus, salicil tus, anabolos stero dus un glikokortiko dus (iz emot r gas lietošanas), peror los pretapaug ošan s l dzek us, tiaz dus, vairogdziedzera hormonus, simpatomim tiskos l dzek us, danazolu, oktreot du un sulfanilam dus.
oral antidiabetic medicinal products, monoamine oxidase (mao) inhibitors, beta-blockers, angiotensin converting enzyme (ace) inhibitors, salicylates, anabolic steroids and glucocorticoids 85 (except topical administration), oral contraceptives, thiazides, thyroid hormones, sympathomimetics, danazol, octreotide and sulphonamides.